ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0553

Lifestyle Interventions in Diabetic Kidney Disease: A Systematic Review Through Life's Essential 8 Lens

Session Information

Category: Cardiovascular-Kidney-Metabolic Health

  • 602 Cardiovascular-Kidney-Metabolic Health: Clinical

Authors

  • Almaraz Aguilar, Oscar David, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
  • Mark, Allyson G., The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
  • Alcocer Gonzalez Camarena, Paulina, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
  • Reyes, Giovanny, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
  • Galan Trujillo, Valeria Beatriz, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
  • Villalbos, Andrea, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
  • Sallam, Hanaa, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
  • Serag, Hani, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
Background

Lifestyle interventions are essential in Type 2 Diabetes (T2D), but their efficacy in established diabetic kidney disease (DKD) remains heterogeneous. The American Heart Association's Life's Essential 8 (LE8) integrates health behaviors and factors that align with the Cardiovascular-Kidney-Metabolic syndrome. Whether current lifestyle interventions in DKD align with the LE8 framework remains unclear. We systematically evaluated whether the DKD lifestyle modification program interventions for patients with DKD align with LE8-defined cardiometabolic outcomes.

Methods

Following PRISMA guidelines, we searched SCOPUS, MEDLINE, and CENTRAL from January 2020 through January 2026 for randomized controlled trials (RCTs) of lifestyle interventions (diet, exercise, education, or self-management) in adults with T2D and DKD (defined by reduced eGFR and/or albuminuria). Pharmacological- only interventions and dialysis-dependent populations were excluded. Screening and data extraction were performed in duplicate using Covidence. An LE8 coverage matrix quantified outcome reporting. A narrative synthesis was performed due to clinical heterogeneity.

Results

Following the screening of 3780 studies, 18 RCTs (N=7,363) were included. Lifestyle interventions were reported to improve the following: 1) eGFR by 5.6%, 2) albuminuria by 30%, 3) LE8 Health Factors, including a) Hemoglobin A1c by 10%, b) Systolic blood pressure by 6%, c) Diastolic blood pressure by 4.3%, d) HDL by 4.3%, and e) BMI by 5%. LE8 Health behaviors, including nicotine exposure and sleep, were minimally or not reported.

Conclusion

Lifestyle interventions in DKD were associated with favorable trends in metabolic and renal outcomes. We recommend that future lifestyle RCTs in DKD include a comprehensive LE8 component assessment to standardize the evaluation of cardiovascular, kidney, and metabolic health